Infinity Clinical research

Hollywood, Florida 33024

0 studies enrolling now · 13 studies all time

What they study most

Alzheimer's Disease, Anti-coagulation Therapy, Atrial Fibrillation, Cervical Dystonia, DVT, Early Alzheimer's Disease, Episodic Migraine, Joint Surgery Multiple, Migraine, With or Without Aura, Multiple Sclerosis, Parkinson Disease, Prosthetic Replacement of Mitral Valve

Studies at this site

• A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease — Running, not enrolling
• A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease — Completed
• A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed
• Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity — Completed
• Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1) — Completed
• Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS) — Completed
• A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease — Completed
• Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine — Completed
• An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine — Completed
• Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention — Completed
• Contrast Media Reduction and Removal in Patients With Chronic Kidney Disease (CKD) (PRESERV) — Stopped early
• Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire — Completed
• Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN) — Paused